Multi-agonist therapy is not bound to gastrointestinal distress in an obese model of PCOS To explore potential gastrointestinal distress linked to multi-agonist interventions, as a putative bias for interpretation of their effects, we conducted kaolin tests in PWA mice
PMC Katagiri K, Koyama S, Takeda K, et al
In addition to its role in cellular defense, the Nrf2 pathway has been implicated in numerous physiological and pathophysiological processes, including aging, neurodegeneration, cancer, and metabolic disorders [77]
For complete information about potential drug interactions, consult the Prescribing Information in Canada: and discuss any concerns with your healthcare provider
It is however a good practice to tell your caregiver about breastfeeding prior to commencing treatment